Q32 Bio Inc. Common Stock (QTTB) is a publicly traded Healthcare sector company. As of September 13, 2026, QTTB trades at $11.11 with a market cap of $330.44M and a P/E ratio of 3.55. QTTB moved +3.59% today. Year to date, QTTB is +234.34%; over the trailing twelve months it is +490.43%. Its 52-week range spans $1.35 to $23.57. Analyst consensus is strong buy with an average price target of $41.00. Rallies surfaces QTTB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
5 analysts cover QTTB: 0 strong buy, 5 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $41.00.
| Metric | Value |
|---|---|
| Price | $11.11 |
| Market Cap | $330.44M |
| P/E Ratio | 3.55 |
| EPS | $3.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $23.57 |
| 52-Week Low | $1.35 |
| Volume | 1.73M |
| Avg Volume | 0 |
| Revenue (TTM) | $53.95M |
| Net Income | $33.79M |
| Gross Margin | 0.00% |
5 analysts cover QTTB: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $41.00.